Rentokil Initial plc reported first‑half 2026 results with Group revenue from continuing operations of $3,589m, up 6.7% (4.5% at constant currency) and organic revenue growth of 3.6%. Adjusted operating profit rose to $556m, up 8.8%, lifting the adjusted operating margin to 15.5%. Free cash flow reached $318m with 96% conversion, and the interim dividend increased 8.0% to 4.48 cents per share.
North America delivered 3.7% organic revenue growth and 10.4% adjusted operating profit growth, supported by cost‑efficiency savings of $45m (annualised run‑rate c.$90m), while International grew revenue 10.7% with 3.5% organic growth. Net debt declined to $3,575m, bringing leverage down to 2.4x adjusted EBITDA, within the stated 2–2.5x target range.
Management recorded an additional $47m provision for termite damage claims, taking the closing provision to $392m and estimating related 2026 cash outflows of $115m–$125m. Despite softer North America Residential lead flow late in Q2 and slower Commercial growth, the company still expects full‑year 2026 profit to be in line with current market expectations.
Rentokil Initial plc reports an update to director information. John Pettigrew, the company’s Senior Independent Director, has been appointed to the board of SSE plc, a company listed on the London Stock Exchange, as a non-executive director with effect from 1 December 2026.
The disclosure is made in accordance with Listing Rule 6.4.9 and is dated 16 July 2026. Further enquiries are directed to Group General Counsel and Company Secretary, Rachel Canham.
Rentokil Initial plc has appointed Rafael “Rafa” Carrasco as Chief Executive Officer, North America, starting on 3 August. He brings extensive experience from WM, where he led large, route-based service operations with more than 200 branches and over 10,000 employees across several countries.
At WM, Rafa held senior roles including President of WM Healthcare Solutions and Senior Vice President of Strategy, focusing on operational efficiency, technology-driven process improvements and recurring revenue models. He also led integration of Stericycle following a $7.2bn acquisition, delivering notable first-year cost synergies.
Interim North America CEO Alain Moffroid will remain on the North America leadership team and support Rafa and the broader growth plan through the end of 2027. Rentokil Initial highlights that it is a global leader in Pest Control and Hygiene & Wellbeing services, employing around 63,400 people in 90 countries.
Rentokil Initial plc filed a notice that institutional investor GIC Private Limited has reduced its voting interest below the 3% disclosure threshold. The change followed security lending activity and reflects a decrease from a previously reported combined holding of 3.186963% of voting rights.
Rentokil Initial plc held its 2026 Annual General Meeting on 7 May 2026, where all 23 resolutions were passed on a poll. Shareholder turnout was high, with around 86% of the issued share capital voting.
Shareholders strongly backed the audited financial statements, with 2,158,322,403 votes for (99.45%), and approved the final dividend with 2,165,477,509 votes for (99.62%). The Directors' Remuneration Report received 92.27% support. All directors standing for election or re-election were endorsed, generally with more than 96% of votes cast in favour, except one re-election that still passed with a clear majority.
Investors also renewed key capital authorities, including the power to allot shares and to make market purchases of the company’s own shares, and approved resolutions to disapply statutory pre-emption rights, with the resolution relating to acquisitions and specified capital investments receiving 86.36% support. The total number of ordinary shares in issue at close of business on 6 May 2026 was 2,526,039,885.
BlackRock Portfolio Management LLC amends a Schedule 13G to report beneficial ownership of 175,098,972 shares of Rentokil Initial plc common stock, representing 6.9% of the class. The filing shows sole voting power for 162,993,738 shares and sole dispositive power for 175,098,972 shares.
The amendment is signed by a BlackRock managing director and reflects holdings reported by certain BlackRock business units under SEC Release No. 34-39538.
Rentokil Initial plc has set the sterling amount for its previously announced final dividend for the year ending 31 December 2025 at 6.10 pence per ordinary share. The dividend was originally declared as 8.24 cents per share, and the conversion uses an exchange rate of GBP1:USD1.3513 based on the average closing spot rates over three working days starting 20 April 2026.
The final dividend remains subject to shareholder approval at the Annual General Meeting on 7 May 2026. If approved, it will be paid on 18 May 2026 to shareholders on the register at the close of business on 10 April 2026.
Rentokil Initial plc, through wholly owned subsidiary Rentokil Terminix Funding plc, has issued senior, unsecured $500 million 4.625% Notes due 2031, guaranteed by the Company. The notes were offered to qualified institutional buyers under Rule 144A and outside the U.S. under Regulation S.
The Company intends to use the net proceeds for general corporate purposes, including debt repayment. Application has been made to list and trade the notes on the Official List and Global Exchange Market of Euronext Dublin.
Rentokil Initial plc reports a TR‑1 notification of major holdings from BlackRock, Inc.. BlackRock’s total holding in Rentokil Initial now represents 13.000000% of voting rights, up from 12.510000% at the previous notification, corresponding to 328889348 voting rights held in the issuer.
The position is split between voting rights attached to shares and financial instruments. Shares carry 263877846 voting rights, equal to 10.440000%. Financial instruments provide an additional 2.560000% of voting rights, including American Depository Receipts and securities lending arrangements, as well as contracts for difference and equity‑linked notes.
Rentokil Initial plc reported first-quarter 2026 revenue of $1,677m, up 4.3% at constant currency with 3.4% Organic Revenue growth. Management described this as a good start in a seasonally quieter period and expressed confidence in delivering a full-year performance in line with market expectations.
North America generated revenue of $995m, up 4.5%, with Pest Control growing organically by 4.1% and strong 12.7% Organic Revenue growth in Business Services helped by pre-spring demand and prior-year contract wins. International revenue was $682m, up 4.1%, with good growth in Europe, Latin America and the UK & Sub-Saharan Africa, partly offset by softer trends in Pacific and MENAT.
By category, Pest Control delivered 3.7% Organic Revenue growth, while Hygiene & Wellbeing grew 2.1% overall, including a decline of (2.7)% organically in North America due to later construction-related revenue. The Group completed 9 bolt-on acquisitions with prior-year annualised revenue of $19m, continuing its M&A-led expansion strategy.